(Q42257442)

English

A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening

scientific article published on 27 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

P Kiely

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

27 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

290-298

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Hepatitis B and residual risk of infection in English and Welsh blood donors, 1996 through 2008.

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk.

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Occult hepatitis B virus infection: implications in transfusion

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Hepatitis B virus infection and transfusion medicine: science and the occult

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Italian blood donors with anti-HBc and occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Characterization of occult hepatitis B virus strains in South African blood donors

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Molecular characterization of occult hepatitis B cases in Greek blood donors.

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Occult hepatitis B virus infection in Thai blood donors

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Transfusion-transmitted hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study.

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Infectivity of blood products from donors with occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Two-sided confidence intervals for the single proportion: comparison of seven methods

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region

1 reference

https://api.crossref.org/works/10.1111%2FVOX.12060

21 January 2018

Identifiers

10.1111/VOX.12060

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42257442&oldid=1940340446"